AARD: Zhang Zhongwei reports a stock award
By AlphaYouPublished Form 4
Zhang Zhongwei
Reporting filer
Zhang Zhongwei reports a stock award, not an open-market purchase or sale, in Aardvark Therapeutics, Inc.. Form 4 filed Oct 8, 2026 lists 1 entry.
- Disclosed
- Oct 8, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) (derivative) | Zhang Zhongwei | 2026-10-07 | A | Grant or award | 127061 | 0 | 127,061 | 1 day | Filed terms
|
Stock Option (right to buy) (derivative)
- Owner
- Zhang Zhongwei
- Date
- 2026-10-07
- Code
- A
- Action
- Grant or award
- Quantity
- 127061
- Price
- 0
- Following holdings
- 127,061
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (right to buy)
- conversion Or Exercise Price: 4.96
- transaction Date: 2026-10-07
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 127061
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-10-07
- underlying Security Title: Common Stock
- underlying Security Shares: 127061
- shares Owned Following Transaction: 127061
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Zhang Zhongwei: Director.
- F1: The option will vest in 36 equal installments on each monthly anniversary of the date of grant such that the shares subject to the option are fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continuous service through each applicable vesting date, inclusive.
Original sources
Prepared automatically from public filing data. Report a correction.